Advertisement

#Amgen

KRAS Blocker Sotorasib Delays Lung Cancer Progression

The drug also showed promise for colorectal and other cancers, but it might work better in combination regimens.

Second KRAS Inhibitor Shows Promise in Early Study

MRTX849 shrank tumors in half of lung cancer patients with a common but difficult to target mutation.

Hitting an Elusive Target

First KRAS targeted therapy shows promise for lung and colon cancer

More Good Results for KRAS Targeted Therapy for Lung Cancer

Half of study participants treated with AMG 510 saw their tumors shrink, and only one experienced disease progression.

Celebrating 10 Years of Collaboration to Prevent Infections in Cancer Patients

I understand how people dealing with a cancer diagnosis are incredibly overwhelmed with information.

KRASG12C inhibitor AMG 510

First KRAS Targeted Therapy Shows Promise for Lung and Colon Cancer

AMG 510 shrank tumors in half of lung cancer patients with a mutation thought to be “undruggable.”

Cancer cells and lymphocytes

Immune Profile for Successful Cancer Immunotherapy Discovered

Multiple immune cell types must be present in tumors for checkpoint inhibitor therapies to be effective.

Advertisement